We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NDAQ:NASDAQNasdaq, Inc. Analysis

Data as of 2026-03-10 - not real-time

$88.05

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nasdaq, Inc. continues to generate strong top‑line growth and robust operating margins, backed by solid free cash flow and a dividend that is comfortably covered by earnings. However, the market price sits well above both the discounted cash‑flow estimate and the industry’s average earnings multiple, indicating that the stock is currently priced for optimism. Technical patterns are neutral, with the short‑term moving average trailing the mid‑term average and the relative strength index hovering around the midpoint, while the MACD histogram shows a modest bullish tilt.
The company’s strategic push into tokenized equities, highlighted by its partnership with a leading crypto exchange, could unlock new revenue streams and enhance its market‑technology positioning. Nevertheless, this initiative introduces additional regulatory scrutiny and operational complexity. Given the blend of solid fundamentals, elevated valuation, and emerging growth catalysts, investors should weigh the upside potential against the heightened valuation and regulatory considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical indicators
  • Valuation appears stretched
  • Upcoming tokenization partnership may need time to materialize

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue and margin expansion
  • Diversification into blockchain‑based services
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash generation and balance‑sheet resilience
  • Long‑term strategic positioning in data and technology infrastructure
  • Moderate regulatory and execution risk from new tokenization initiatives

Key Metrics & Analysis

Financial Health

Revenue Growth13.40%
Profit Margin34.06%
P/E Ratio28.5
ROE15.25%
ROA5.05%
Debt/Equity77.88
P/B Ratio4.1
Op. Cash Flow$2.3B
Free Cash Flow$1.7B
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI51.6
Support$77.09
Resistance$90.42
MA 20$84.20
MA 50$91.95
MA 200$90.46
MACDBullish
VolumeDecreasing
Fear & Greed Index79.73

Valuation

Fair Value$55.33
Target Price$108.53
Upside/Downside23.26%
GradeOvervalued
TypeGrowth
Dividend Yield1.23%

Risk Assessment

Beta0.90
Volatility42.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.